Yum! Brands is the world's leading restaurant company with more than 40,000 restaurants in over 125 countries. Yum! is ranked #216 on the Fortune 500 List with revenues of more than $13 billion in 2013.
Focused on developing biologic and drug candidates for the prevention and treatment of serious infections and other diseases, including C-IBS, C. difficile infection, Pertussis, Acinetobacter infections and multiple sclerosis.